Synta Pharmaceuticals Drops Phase 3 Lung Cancer Trial
October 22, 2015 at 06:15 AM EDT
Shares of Synta Pharmaceuticals tumbled 63% yesterday after the compnay stated, it has completely dropping its phase 3 lung cancer trial.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
